Life Sciences

In the constantly evolving landscape, life sciences companies are trying to address uncertainties while bringing new discoveries and innovative solutions to life.

The Life-science Industry is facing daunting pressures for cost reduction that are forcing leaders to rethink their business models.
Payors are tightly supporting a sustainable and lean healthcare system with ongoing austerity measures tackling runaway healthcare costs to increase access to care. Empowering patients, more knowledgeable and info/data driven, are becoming more capable of managing their own health and are thus requiring more customer centric approach to industry players.

Our professionals have significant healthcare/pharma experience, working with leading payors, providers, regulators and industry associations and allowing to forge connections among industry stakeholders always providing a unique perspective on the rapidly changing value chain of the industry.

Industry competition is increasing due to new local players in emerging countries and the ongoing consolidation wave is forcing industry players to review their international strategy.
In this context, the reduced research and development (R&D) return on investment and the increased generics utilization paired with relevant patent cliff are mounting the urgency to rethink the current companies’ business models in order to be competitively positioned in this global market.

We help you to:

• speed up the journey from lab to market
• simplify business structures to keep costs down and stay compliant
• turn capabilities into commercial propositions
• transform your business model to capitalise on your strengths
• form new partnerships to make the most of discoveries.